Micki Klearman
Direktor/Vorstandsmitglied bei KEZAR LIFE SCIENCES, INC.
Vermögen: - $ am 30.04.2024
Profil
Micki Klearman is an Independent Director at Kezar Life Sciences, Inc. He previously worked at Genentech, Inc. as an Associate Group Medical Director-Immunology from 2007 to 2018.
He received his undergraduate degree from Stanford University and his doctorate from Washington University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
-.--% | 01.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Micki Klearman
| Unternehmen | Position | Beginn |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.06.2021 |
Ehemalige bekannte Positionen von Micki Klearman
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Micki Klearman
| Washington University School of Medicine | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
